A Prospective, Single-arm Exploratory Trail of Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
This is a prospective, single-arm exploratory study to evaluate the efficacy and safety of chemotherapy combined with Adebrelimab and Apatinib as the perioperative treatment in Patients With Biliary Tract Cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• confirmed intrahepatic cholangiocarcinoma
• with Resectable tumor lesion
• no contraindications to surgery
• with high risk of tumour recurrence
• No prior systemic therapy for intrahepatic cholangiocarcinoma.
• ECOG Performance Status of 0 or 1
• Child-Pugh Class: Grade A
Locations
Other Locations
China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RECRUITING
Guangzhou
Contact Information
Primary
Yajin Chen
cyj0509@126.com
13719006202
Backup
Changzhen shang
shangchangzhen@139.com
13711279678
Time Frame
Start Date: 2024-03-01
Estimated Completion Date: 2028-03-31
Participants
Target number of participants: 40
Treatments
Experimental: treatment arm
Related Therapeutic Areas
Sponsors
Leads: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University